CyberKnife® M6™

 

The Ella Milbank Foshay Jupiter Medical Center CyberKnife Robotic RadiosurgeryCancer Center is the first center in Florida, and one of only a handful in the nation, to offer the next generation in radiosurgery: the CyberKnife® M6™. A leap forward in cancer care, the M6™ is the most advanced and accurate CyberKnife® System in use today. It is a non-surgical, pain-free treatment option for many patients who have inoperable or surgically complex tumors, or who may be looking for an alternative to surgery.

The radiation oncology team at Jupiter Medical Center is now treating cancer patients using the first and only robotic radiosurgery system. This robotic technology is critical in allowing the CyberKnife System to deliver uniquely angled radiation beams in many different directions. By precisely targeting the tumor, the robotic CyberKnife System can deliver a maximum dose of radiation directly to the tumor with sub-millimeter precision, while minimizing radiation to nearby healthy organs and tissues. It is designed to treat cancerous and non-cancerous tumors anywhere in the body, including the head, spine, lung, prostate, liver and pancreas.
 

“At Jupiter Medical Center, we take pride in offering the most adAnthony Addesa, MD,vanced cancer treatment options available,” said Anthony Addesa, MD, Medical Director of Radiation Oncology. “The CyberKnife M6 System represents a significant leap forward in innovative, non-invasive cancer treatment by allowing our clinicians to offer the most personalized care delivered with unparalleled accuracy, ensuring each patient receives the best treatment available.”

 

 

Benefits of CyberKnife Treatments

  • Pain-free
  • Non-invasive
  • No anesthesia required
  • Outpatient procedure
  • Exceptional accuracy spares healthy tissue and organs
  • No recovery time
  • Immediate return to normal activities
  • Non-invasive head or body frame
  • No breath holding or “respiratory gating” required during treatments


The CyberKnife M6 System offers unique capabilities that not only track tumor movement, but also automatically correct for motion throughout treatment. The ability to manage motion in real time helps ensure radiation is delivered only to the tumor while sparing healthy tissue. It is particularly helpful for treating tumors of the lung, liver and prostate, where movement is common. Research shows a reduction in radiation exposure to healthy tissue helps reduce side effects associated with treatment. In addition, the CyberKnife System’s robotic arm allows for the delivery of radiation from any angle without the need to reposition the patient on the treatment table.

 

Backed by numerous peer-reviewed studies supporting its safety and efficacy, the CyberKnife System provides a pain-free, non-invasive option for patients who are looking for an alternative to surgery and for patients who have inoperable or surgically complex tumors. In addition, the CyberKnife System is increasingly being used as an alternative to conventional radiation therapy, allowing for a shorter course of treatment. In fact, CyberKnife treatment is typically completed in just one to five days, instead of a week of treatment sessions often required with conventional radiation therapy, and, unlike surgery, requires no anesthesia or recovery time.